BMO Capital analyst Bhavesh Lodaya lowered the firm’s price target on Olin (OLN) to $34 from $44 and keeps a Market Perform rating on the ...

BMO Capital lowered the firm’s price target on FMC (FMC) to $50 from $62 and keeps a Market Perform rating on the shares after its Q4 results ...

BMO Capital Markets has recently initiated Aflac Inc (AFL) stock to Market Perform rating, as announced on January 23, 2025, according to Finviz. Earlier, on October 9, 2024, TD Cowen had initiated ...

Adtalem Global Education (NYSE:ATGE – Get Free Report) had its price objective lifted by equities researchers at BMO Capital Markets from $108.00 to $115.00 in a note issued to investors on ...

Co. Inc. (NYSE:MRK), reducing the pharmaceutical giant's price target from $105.00 to $96.00, while keeping a Market Perform rating on the stock. Analysts at BMO Capital cited a decrease in confidence ...

BMO Capital Markets adjusted its outlook on Willis Towers Watson (NASDAQ:WTW), reducing the firm's price target from $325.00 to $320.00. Despite the adjustment, the analyst maintained a Market Perform ...

NIKE (NYSE:NKE – Get Free Report) had its price objective raised by BMO Capital Markets from $92.00 to $95.00 in a research note issued on Monday,Benzinga reports. The firm presently has an ...

In terms of valuation, 4D Molecular Therapeutics Inc’s market capitalization stands at $273.67 million. Market cap represents the total value of all outstanding shares and is a key indicator of a ...

BMO Capital Markets downgraded Everest Group to Market Perform due to deeper underwriting issues and a $1.7B reserve charge, ...

Bank of Montreal dismissed a managing director on its U.S. mortgage-backed bond desk in connection with a regulatory probe ...

The Canada-based bank dismissed the leader from its capital markets arm following a multimillion-dollar penalty to settle ...

Galiano Gold downgraded by BMO Capital after revised five-year outlook for Asanko gold mine in Ghana, facing lower production ...